INCYTE CORPORATION Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
INCYTE CORPORATION (INCY) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of -$2.97 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-02-10
- INCYTE CORPORATION effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was -$2.97M, a 162.70% decline from fiscal 2024.
- INCYTE CORPORATION effective income tax rate reconciliation, other adjustments, amount for fiscal 2024 was $4.74M.
- INCYTE CORPORATION effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was -$947.00K.
- INCYTE CORPORATION effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was -$564.00K, a 115.59% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$2.97M 10-K · filed 2026-02-10 | |
| 2024-12-31 | $4.74M 10-K · filed 2026-02-10 | |
| 2023-12-31 | -$947.00K 10-K · filed 2026-02-10 | $5.00M 10-K · filed 2024-02-13 |
| 2022-12-31 | -$564.00K 10-K · filed 2025-02-10 | $2.70M 10-K · filed 2023-02-07 |
| 2021-12-31 | $3.62M 10-K · filed 2024-02-13 | |
| 2020-12-31 | $2.48M 10-K · filed 2023-02-07 | $1.07M 10-K · filed 2021-02-09 |
| 2019-12-31 | $5.10M 10-K · filed 2022-02-08 | $3.26M 10-K · filed 2020-02-13 |
| 2018-12-31 | $550.00K 10-K · filed 2021-02-09 | |
| 2017-12-31 | $550.00K 10-K · filed 2020-02-13 | |
| 2016-12-31 | $506.00K 10-K · filed 2019-02-14 | |
| 2015-12-31 | $578.00K 10-K · filed 2018-02-15 | $456.00K 10-K · filed 2016-02-12 |
| 2014-12-31 | $369.00K 10-K · filed 2017-02-14 | $1.20M 10-K · filed 2015-02-17 |
| 2013-12-31 | $277.00K 10-K · filed 2016-02-12 | $1.25M 10-K · filed 2014-02-21 |
| 2012-12-31 | $410.00K 10-K · filed 2015-02-17 | $786.00K 10-K · filed 2013-02-21 |
| 2011-12-31 | $235.00K 10-K · filed 2014-02-21 | $575.00K 10-K · filed 2012-02-22 |
| 2010-12-31 | $289.00K 10-K · filed 2013-02-21 | |
| 2009-12-31 | $1.48M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |